Tapping into the influence of keratinocyte allografts and biocenosis on healing of chronic leg ulcers: split-ulcer controlled pilot study. by Paquet, Philippe et al.
Tapping into the Influence of Keratinocyte Allografts and
Biocenosis on Healing of Chronic Leg Ulcers: Split-Ulcer
Controlled Pilot Study
PHILIPPE PAQUET, MD, PHD, PASCALE QUATRESOOZ, MD, CATHERINE BRAHAM, MD, AND GÉRALD E. PIÉRARD,
MD, PHD
Department of Dermatopathology, University Hospital of Liège, Liège, Belgium
BACKGROUND. Cultured keratinocytes may represent an alterna-
tive therapy aiming at boosting leg ulcer healing. There is no evi-
dence-based study comparing objectively the healing rate of split-
ulcer portions covered or not covered by cultured keratinocytes.
OBJECTIVE. To assess the effect of cultured keratinocytes on the
healing rate of leg ulcers.
METHOD. Five applications of fresh (cela, XCELLentis, Ghent,
Belgium) or frozen (CryoCeal, XCELLentis) cultured allogeneic
keratinocytes were performed at weekly intervals to treat large
leg ulcers (mean diameter > 5 cm) in four patients. A split-ulcer
study was designed to secure a control area covered only by
petrolatum gauze. Clinical, planimetric, bacteriologic, and
immunohistologic assessments of the keratinocyte-treated and
control parts of the ulcers were performed.
RESULTS. Compared with controls, planimetry revealed a benefi-
cial effect afforded by cryopreserved cultured keratinocytes on
the ulcer healing rate of two of four ulcers (+12 and 81%). The
healing effect was obtained on the ulcers associated with the low-
est bacterial load. Cultured keratinocytes did not qualitatively
and quantitatively modify the ulcer biocenosis. They did not
affect the number of any type of inflammatory cells present in the
granulation tissue (type I dermal dendrocytes, macrophages, T
lymphocytes, granulocytes). No specific side effect of cultured
keratinocytes was evidenced.
CONCLUSION. In this small case series, it appears that cultured
allogeneic keratinocytes may be helpful in the healing process of
venous leg ulcers. However, a clean wound with reduced bacter-
ial load seems to be the prerequisite condition for obtaining a
beneficial effect. 
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CULTURED ALLOGENEIC keratinocytes have been
advocated for years for the treatment of chronic leg ulcers
of various origins.1–4 Graft rejection is not a problem
because cultured keratinocytes exhibit low immunogenic-
ity. Cultured keratinocytes probably produce a large reper-
toire of cytokines, adhesion molecules, growth factors,
and basement membrane components able to modulate
wound healing.5–7 Cultured keratinocytes may exert some
antimicrobial activity through a mechanism of innate
immunity, probably involving the release of antibiotic pep-
tides.8 Such an activity might be important because
microorganisms of many species are often abundant in
chronic leg ulcers.9 At a critical contamination level, this
enriched biocenosis can impede the healing process.10–12
The histologic changes in the wound bed following
application of cultured keratinocytes have not been thor-
oughly studied so far. We presently report a split-ulcer
pilot study comparing the healing rate under the influence
of fresh or frozen cultured allogeneic keratinocytes. We
also describe the changes in different cell populations in
the wound bed and the evolution in the composition and
amount of the bacterial flora.
Materials and Methods
This open-label, randomized pilot study was conducted in
accordance with the Declaration of Helsinki (1996) and its
subsequent amendments. The protocol was approved by
the local ethics committee. A written informed consent
was obtained from each patient at the screening visit.
Four women aged 61 to 83 years were enrolled. They
suffered from chronic venous leg ulcers that were unre-
sponsive to conventional medical care for at least 3
months. The ulcers had an average diameter greater than
5 cm but did not extend to the fascia. No signs of micro-
bial infection were present. Venous insufficiency of the
affected leg was demonstrated using duplex ultrasonogra-
Address correspondence and reprint requests to: Gérald E. Piérard,
MD, PhD, Department of Dermatopathology, CHU Sart Tilman, B-
4000, Liège, Belgium, or e-mail gerald.pierard@ulg.ac.be.
phy and by the presence of hyperpigmentation or vari-
cosities in the surrounding skin. One patient (patient 1)
was taking immunosuppressive medication in moderate
doses following a liver transplant in 1996.
During a 2-week run-in period, the wound care per-
formed by a specialized nurse consisted of alginate, hydro-
colloid, foam, or hydrogel dressings according to the
appearance of the ulcer. The ulcer was then again evaluated
to ensure that the open wound area had not increased or
decreased by more than 30% during the 2-week run-in
period.
Prior to application of the study products, ulcers were
débrided and cleaned by gently dripped sterile saline.
Other cleansers were not used. At week 0, the randomized
investigational products were applied for the first time on
half of the ulcer. The other half part was covered by petro-
latum gauze only. An absorbent pad and a compression
bandage (Rosidal, Stella, Chenee, Belgium) were applied
and left in place for 7 days. The study treatment was reap-
plied weekly for 4 consecutive weeks. Safety was evaluated
by recording adverse events at each study visit: clinical
evaluation (ulcer aspect, vital signs, physical examination),
laboratory assessments (hematology, biochemistry), and
bacterial evaluations by swabs.
Photographs and wound tracings were performed at
weeks 3, 1, 0, 2, 4, 6, and 8. The areas of the ker-
atinocyte-treated and control parts was measured using
computerized planimetry (Mop Videoplan Kontron, Eich-
ing, Germany) of surface tracing drawn on plastic sheets,
using a previously described method.11,13,14 The rate of
healing or extension of the leg ulcers at completion of the
treatment was measured using the healing index. Healing
index adjusted to the initial perimeter (HIP, mm), was cal-
culated as follows:
HIP = 
The histologic aspects of the ulcers were assessed on
3 mm punch biopsies taken at weeks 0, 2, 4, and 6 in the
center of each half part of the ulcers. Histology and
immunohistochemistry were performed (Table 1). Com-
puterized image analysis was used to quantify the different
cell populations in the superficial and deep parts of the
granulation tissue. A mean percentage of the area occupied
by the different populations in the corresponding tissue
was established in three representative microscopic fields.
These measurements were performed by one single-blind
investigator.
Wound swabs on keratinocyte-treated and control parts
were performed at weeks 0 and 6 for culture and Gram
stain examination. Semiquantitative evaluations of the




Planimetry data are summarized in Table 2. The effect of
treatment showed large interindividual variability. At com-
pletion of the study, a positive effect was noticed in two of
four patients who experienced a 12% and an 81% greater
HIP on the CryoCeal-treated part, respectively (Figures 1
and 2). No beneficial effect of keratinocyte grafts was
recorded on the ulcer size in the two other patients.
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Table 1. Panel of Antibodies
Antibody Source Dilution Specificity
Mo, UCHL-1 anti-CD45R0 Dako 1/100 Mature T cells
Po, anti–factor XIIIa BioGenex 1/300 Type I dendrocytes
Mo, anti-CD15 Dako 1/50 Granulocytes
Mo, Mac 387, anti-L1 Dako 1/100 Monocytes/macrophages
Mo = monoclonal; Po = polyclonal.
Table 2. Ulcer Healing Characteristics in a Split-Ulcer Design
Patient/Age, yr Keratinocyte-Treated Area, Control Area, HIP Difference
HIP (mm), D42 HIP (mm), D42
mm %
1/79 Proximal Ceal +7.4 Distal +5 +2.4 +48
2/61 Proximal CryoCeal +5.3 Distal 0.8 +6.1 +610
3/75 Distal CryoCeal 4.7 Proximal 4.2 0.5 12
4/83 Proximal Cryoceal 4 Distal 2.2 1.8 81
D = day; HIP
actual ulcer area  initial ulcer area
initial perimeter
Histology and Immunohistology
All biopsy specimens taken from each half part of the
ulcers before and during the study showed granulation tis-
sue with inflammatory cells and discrete vasculitis in both
the keratinocyte-treated and control parts of the ulcers.
No difference was correlated with the clinical evolution of
the ulcers. Compared with the control areas, no specific
influence of keratinocyte grafts was observed on the dif-
ferent cell populations in the superficial or deep granula-
tion tissue (Table 3). The healing propensity of the ulcers
seemed to be clearly associated with a greater number in
factor XIII+ dendrocytes combined with a moderate num-
ber of Mac 387+ macrophages in the superficial part of the
granulation tissue and rare CD15+ granulocytes. No rela-
tionship was found between the number of CD45RO+ T
lymphocytes and the healing rate.
Microbiology
Healing ulcers in two patients were clearly associated with
a lower bacterial load at baseline (Table 4). The qualitative
standpoint revealed a limited number of Staphylococcus
aureus and the absence of both Enterococcus faecalis and
Pseudomonas aeruginosa on healing wounds. In the two
other patients, cultured keratinocytes did not prevent the
growth of bacterial strains such as Escherichia coli and E.
faecalis.
Safety
No safety issues were recorded during the study period.
Discussion
The effect of cultured keratinocytes on leg ulcer healing
was often assessed in prospective, open, uncontrolled stud-
ies. In all trials, more meticulous medical care, including
the correct use of compression bandages and rest in bed
after grafting, likely improved the leg ulcer, irrespective of
the effect of keratinocyte grafting. Only one study used a
control group of patients distinct from those receiving the
cultured cells.2
In the present pilot study, a split-ulcer design was used
to secure a control area only covered by petrolatum gauze.
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Figure 1. Leg ulcer in patient 4 at inclusion.
Figure 2. Leg ulcer of patient 4 1 week after completion of the split-
ulcer treatment. The CryoCeal-treated part (A) shows a reduction in
size that is 81% superior to the evolution at the control site (B) cov-
ered by petrolatum gauze only.
Two of the four ulcers appeared to benefit from the ker-
atinocyte graft. In these cases, a positive edge effect of the
cultured keratinocytes on the untreated area cannot be
ruled out. Hence, the healing rate difference was probably
greater than that measured. The positive effect on healing
was obtained with cryopreserved keratinocytes, suggesting
that frozen cultured sheets retained some healing potential
on ulcers that were the least colonized by microorganisms.
It is possible that a prerequisite condition for greater ker-
atinocyte graft effectiveness is a low bacterial ulcer load.
Even if innate immunity expressed by cultured ker-
atinocytes exhibits inhibitory effects on bacterial growth
in vitro,8 such a property cannot fully control a critical
bacterial colonization in vivo in the particular environ-
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Table 3. Relative Area (%) Covered by Immunoreactive Inflammatory Cells
Keratinocyte-Treated Area Control
Antibody/Patient D0 D42 Difference D0 D42 Difference
Sup Deep Sup Deep Sup Deep Sup Deep Sup Deep Sup Deep
FactorXIIIa 0.5 5.9 0.6 8.4 0.1 2.5 4.1 2.2 0.5 10.1 3.6 7.9
1 9 8 2 0.5 7 6.5 1 0.2 3.9 0.2 2.9 0
2 0.4 0.4 6 5.9 5.6 5.4 0.5 1.1 8.3 6 7.8 4.9
3 10.2 7.6 9.3 4 0.9 3.6 14.2 7.2 9 3 5.2 4.2
4
CD45R0
1 4 4 5 5 0 0 9 10 9.8 3.8 0.8 6.2
2 13 12 0.1 0.1 12.9 11.9 27 47 15 14 -12 33
3 5.2 4.9 0.5 1 4.7 3.9 4 5 4 5 0 0
4 5 0.5 8 4 3 3.5 4 2 6.5 3 3.5 0.5
CD15
1 8 6 10 6 2 0 7 7 9 4 2 3
2 15 30 15 25 0 5 22 27 24 24 2 3
3 6 9 2 1 -4 8 7 5 7 3 0 2
4 5 0.1 7 1.5 2 1.4 3 0.1 3.5 0.2 0.5 0.1
Mac 387
1 22 20 23 19 1 1 20 19 19 25 1 6
2 35 30 14 9 21 21 65 58 27 20 38 38
3 15 15 11 15 4 0 14 14 17 16 3 2
4 20 5 11 8 9 3 17 17 11 9 8 6
Sup = superficial.
Table 4. Ulcer Biocenosis before (D0) and after a 42-Day Treatment (D42)
Patient Keratinocyte-Treated Area Control Area
D0 D42 D0 D42
1 Pseudomonas aeruginosa ++ P. aeruginosa +++ P. aeruginosa ++ E. faecalis ++
Staphylococcus aureus ++ Enterococcus faecalis ++ S. aureus ++
2 Escherichia coli ++ E. coli +++ E. coli ++ E. coli ++
E. faecalis ++ Acinetobacter calcoa E. faecalis ++ A. calcoa
Bacillus anitratus +++ B. anitratus +++
3 Klebsiella oxytoca + Proteus mirabilis  K. oxytoca + P. mirabilis +
S. aureus + S. aureus  S. aureus + S. aureus +
Group G streptococcus  Group G streptococcus +
4 S. epidermidis  Coagulase-negative staphylococcus  S. epidermidis  Various gram + bacteria 
Number of colonies at culture:  = few; + = moderate; ++ = numerous; +++ = abundant.
ment of a leg venous ulcer.9 Hence, an appropriate pre-
grafting preparation of the ulcer bed would probably ben-
efit from antiseptics, stopping their applications just before
grafting to avoid toxicity on the cultured cells.15,16 The
nature of the bacteria present in the ulcers is also impor-
tant. The classic pathogenic strains of pyogenic cocci (S.
aureus, Enterococcus) and enteric gram-negative microor-
ganisms (Pseudomonas and E. coli) produce exotoxins,
leading to severe inflammation and tissue necrosis.15
In some of our patients, cultured cells had a significant
effect on the amount of inflammatory cells, including fac-
tor XIIIa+ dendrocytes, CD15+ granulocytes, Mac 387+
macrophages, and CD45RO+ T lymphocytes. However, an
effect on the functional capacities of these cells cannot be
ruled out. Histologically, the healing process was associ-
ated with both an increased number of factor XIIIa+ den-
drocytes and a decreased number of granulocytes and
macrophages. The nonhealing ulcers did not show these
features. Factor XIIIa+ dendrocytes share phagocytic and
antigen-presenting properties.17,18 They also release some
cytokines and growth factors contributing to the forma-
tion of the granulation tissue.17 Infiltrating neutrophils
and macrophages can also help clean the wounded areas,
fragments of extracellular matrix, and bacteria.6,7
Macrophages are able to produce various growth factors
and cytokines, which may prove to be deleterious on heal-
ing. The decreased number of infiltrating neutrophils and
macrophages in healing conditions is probably associated
with a cleaner wound bed and decreased inflammation,
helping reepithelialization.6,7
In conclusion, the results of this small case series are
comparable with those obtained with other bioengineered
skin material. Even if no firm conclusions can be drawn
from this limited controlled pilot study, a moderate effect
of allogeneic cultured keratinocytes on the healing of
venous leg ulcer was seen in some cases. A clean wound
with a limited bacterial load seems to be a prerequisite
condition for a positive effect. Cultured allogeneic ker-
atinocytes appear to be unable to down-regulate a critical
bacterial colonization or to significantly modify the nature
and amount of the cellular infiltrate in the granulation tis-
sue. Future studies might take into account lateral side by
side placement of the test material on the skin defect, as
well as the use of fresh and cryopreserved cells and differ-
ing bacterial loads.
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